Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products. Founded by Jay Shukla in 2009, Nivagen Pharmaceuticals is backed by investors that include Telegraph Hill Partners and is headquartered in Sacramento.